According to Alnylam Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$4.11. In 2022 the company made an earnings per share (EPS) of -$9.29 a decrease over its 2021 EPS that were of -$7.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.11 | -55.76% |
2022 | -$9.29 | 29.03% |
2021 | -$7.20 | -3.36% |
2020 | -$7.45 | -8.48% |
2019 | -$8.14 | 7.67% |
2018 | -$7.56 | 39.74% |
2017 | -$5.41 | 12.94% |
2016 | -$4.79 | 38.84% |
2015 | -$3.45 | -32.88% |
2014 | -$5.14 | 259.44% |
2013 | -$1.43 | -31.25% |
2012 | -$2.08 | 52.94% |
2011 | -$1.36 | 30.77% |
2010 | -$1.04 | -8.77% |
2009 | -$1.14 | 78.13% |
2008 | -$0.64 | -70.78% |
2007 | -$2.19 | 99.09% |
2006 | -$1.10 | -43.88% |
2005 | -$1.96 | -82.33% |
2004 | -$11.09 | -59.23% |
2003 | -$27.21 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | -191.00% | ๐จ๐ญ Switzerland |
Sanofi SNY | $3.18 | -177.38% | ๐ซ๐ท France |
Regeneron Pharmaceuticals REGN | $37.36 | -1,009.00% | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | -$7.83 | 90.51% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | -$1.69 | -58.88% | ๐บ๐ธ USA |
OPKO Health
OPK | -$0.27 | -93.43% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | -51.34% | ๐ฎ๐ฑ Israel |
Arrowhead Pharmaceuticals
ARWR | -$1.70 | -58.64% | ๐บ๐ธ USA |